Global Hemostats Market 2018-2023 by Product, Application, Formulation - Market is Expected to Reach USD 3.03 Billion

DUBLIN, Sept. 19, 2018 /PRNewswire/ --

The "Hemostats Market by Product (Thrombin, Oxidised Regenerated Cellulose, Combination, Gelatin, Collagen), Application (Gynecology, Neurology, Cardiovascular, Reconstructive), Formulation (Powder, Matrix & Gel, Sheets & Pads) - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.

The global hemostats market is expected to reach USD 3.03 billion by 2023 from USD 2.27 billion in 2018, at a CAGR of 6.0%

Growth in this market is driven by the increasing number of surgical procedures, growing number of regulatory approvals, increasing incidence of sports-related injuries and spinal ailments, and rising focus on effective blood loss management in patients during surgeries. In addition, the emerging markets and growth in the number of hospitals and surgical centers are expected to offer further growth opportunities for players operating in the hemostats market during the forecast period.

The global hemostats market is segmented by product, application, formulation, and region.

Based on applications, the hemostats market is segmented into neurological surgery, cardiovascular surgery, general surgery, orthopedic surgery, thoracic surgery, gynecological surgery, urological surgery, and reconstructive surgery. The orthopedic surgery segment is expected to account for the largest share of the hemostats market in 2018. The growing geriatric population, increasing incidence of sports injuries, and the growing prevalence of lifestyle disorders (such as arthritis, osteoporosis, and obesity) are some of the major factors responsible for the growth in the number of orthopedic surgeries performed globally. The growing number of orthopedic surgeries is in turn expected to support the growth of dependent markets, such as the hemostats market for orthopedic applications.

Based on product, the hemostats market is segmented into thrombin-based hemostats, oxidized regenerated cellulose-based hemostats, combination hemostats, gelatin-based hemostats, and collagen-based hemostats. The thrombin-based hemostats segment is expected to account for the largest share of the market in 2018. The large share of this market segment can primarily be attributed to the wide range of advantages associated with the use of thrombin-based hemostats.

Based on formulation, the hemostats market is further segmented into matrix & gel hemostats, sheet & pad hemostats, sponge hemostats, and powder hemostats. In 2018, the matrix & gel hemostats segment is expected to account for the largest share of the hemostats market. The large share of this market segment can primarily be attributed to the advantages associated with the use of these formulations, such as lightweight and ease of use. Sponge hemostats, on the other hand, are expected to witness the highest growth in the market during the forecast period. Market growth can largely be attributed to the growing acceptance of these formulations by end users.

The major players in the hemostats market include CR Bard, Inc. (US). B. Braun Melsungen AG (Germany), Baxter International, Inc. (US), Integra LifeSciences (US), Marine Polymer Technologies, Inc. (US), Teleflex (US), Ethicon, Inc. (US), Pfizer, Inc. (US), Z-Medica LLC (US), and Gelita Medical GmbH (Germany).

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

4.1 Hemostats: Market Overview
4.2 Asia Pacific: Hemostats Market, By Formulation (2018)
4.3 Hemostats Market, By Region (2018)
4.4 Geographical Snapshot of the Hemostats Market

5 Market Overview

5.1 Introduction
5.2 Market Dynamics
5.3 Drivers
5.3.1 Increasing Number of Surgical Procedures
5.3.2 Growing Number of Regulatory Approvals
5.3.3 Increasing Incidence of Sports-Related Injuries and Spinal Ailments
5.3.4 Rising Focus on Effective Blood Loss Management in Patients During Surgeries
5.4 Market Opportunities
5.4.1 Growth in the Number of Hospitals & Surgical Centers
5.4.2 Emerging Markets
5.5 Market Restraints
5.5.1 Product Recalls
5.5.2 Highly Consolidated Market
5.6 Market Challenges
5.6.1 Dearth of Skilled Personnel
5.6.2 High Cost of Hemostats

6 Hemostats Market, By Product

6.1 Introduction
6.2 Thrombin-Based Hemostats
6.3 Oxidized Regenerated Cellulose-Based Hemostats
6.4 Combination Hemostats
6.5 Gelatin-Based Hemostats
6.6 Collagen-Based Hemostats

7 Hemostats Market, By Formulation

7.1 Introduction
7.2 Matrix & Gel Hemostats
7.3 Sheet & Pad Hemostats
7.4 Sponge Hemostats
7.5 Powder Hemostats

8 Hemostats Market, By Application

8.1 Introduction
8.2 Orthopedic Surgery
8.3 General Surgery
8.4 Neurological Surgery
8.5 Cardiovascular Surgery
8.6 Reconstructive Surgery
8.7 Gynecological Surgery
8.8 Other Surgeries

9 Hemostats Market, By Region

10 Competitive Landscape

10.1 Overview
10.2 Market Share Analysis
10.3 Competitive Scenario
10.3.1 Product Launches and Approvals
10.3.2 Acquisitions
10.3.3 Agreements
10.3.4 Expansions

11 Company Profiles

11.1 C. R. Bard
11.2 B.Braun
11.3 Baxter
11.4 Integra Lifesciences
11.5 Marine Polymer Technologies
11.6 Pfizer
11.7 Gelita Medical GmbH
11.8 Z-Medica, LLC
11.9 Ethicon (Subsidiary of Johnson & Johnson)
11.10 Teleflex Incorporated

For more information about this report visit https://www.researchandmarkets.com/research/pr73sp/global_hemostats?w=5

Media Contact:

Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets